New biochemical markers in Alzheimer disease

Archives of Neurology

Volumn 58, Issue 3, 2001, Pages 354-356

  Diaz Arrastia, R ^a   Baskin, F ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN A1; BETA SECRETASE; DNA; GAMMA SECRETASE; HEME OXYGENASE; PRESENILIN 1; PRESENILIN 2; TAU PROTEIN;

ALZHEIMER DISEASE; DISEASE MARKER; EDITORIAL; HUMAN; NERVE DEGENERATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL;

EID: 0035106869     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.58.3.354     Document Type: Editorial

References (20)

1. Genetic factors in Aizheimer's disease: A review of recent advances
2. Alzheimer Disease. Mouse models pave the way for therapeutic opportunities
3. Chemokines/chemokine receptors in the central nervous system and Alzheimer's disease
4. Risk of Alzheimer's disease and duration of NSAID use
5. Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease
6. Immunization with amyloid-β attenuates Alzheimer-disease-like pathologyin the PDAPP mouse
7. Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sample
8. Tau protein in cerebrospinal fluid is significantly increased at the earliest clinical stage of Alzheimer disease
9. Combination assay of CSF tau, Aβ 1-40 and Aβ 1-42(43) as a biochemical marker of Alzheimer's disease
10. Combined assessment of tau and neuronal thread protein in Alzheimer's disease CSF
11. Improved discrimination of AD patients using beta-amyloid (1-42) and tau levels in CSF
12. Discriminant power of the combined cerebrospinal fluid tau protein and of the soluble interleukin-6 receptor complex in the diagnosis of Alzheimer's disease
13. Decreased high-density lipoprotein cholesterol and serum apolipoprotein Al concentrations are highly correlated with the severity of Alzheimer's disease
14. Evaluation of heme oxygenase-1 as a systemic biological marker of sporadic AD
15. Altered amyloid protein processing in platelets of patients with Alzheimer disease
16. Platelet APP isoform ratics correlate with declining cognition in AD
17. The role of oxidative stress in Alzheimer disease
18. An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease
19. Increased nuclear DNA oxidation in the brain of Alzheimer's disease